We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Microgen | LSE:MCGN | London | Ordinary Share | GB00BVVHWX30 | ORD 6 3/7P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 367.50 | 365.00 | 370.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMMCGN
RNS Number : 9974U
Microgen PLC
25 January 2017
microgen
www.microgen.com
25 January 2017
BUSINESS UPDATE & NOTICE OF RESULTS
Microgen plc ('Microgen' or 'the Group') anticipates issuing its preliminary results for the year ended 31 December 2016 on 8 March 2017.
The Group made excellent progress in the second half of 2016 in line with its declared strategy. The highlight for the Group was the continued progress of the Aptitude Software business which entered into ten contracts in 2016 with new clients located across Europe, North America and Asia (new market) resulting in an increase during the year of approximately 40% in Aptitude Software's year end on-going recurring revenue base.
The Microgen Financial Systems business continued to develop its focus on the Trust & Fund Administration ("T&FA") market in 2016 with the integration of the May 2016 acquisition of Infoscreen progressing in line with expectations. As a result of both organic growth and the benefit from the recent add-on acquisitions, T&FA revenues in 2016 represent in excess of 50% of Microgen Financial Systems' revenues.
At 31 December 2016, the Group had gross cash of GBP23.8 million (2015: GBP18.6 million) and net funds of GBP13.6 million (2015: GBP5.4 million) following net corporate cash outflows of GBP1.5 million in 2016 (dividends of GBP2.5 million, GBP1.4 million net acquisition costs and GBP2.4 million property proceeds).
Contacts
Ivan Martin, Chairman 020-7496-8100
Philip Wood, Chief Financial Officer
Darius Alexander, FTI Consulting 020-3727-1063
This information is provided by RNS
The company news service from the London Stock Exchange
END
NOREALFLALAXEFF
(END) Dow Jones Newswires
January 25, 2017 02:00 ET (07:00 GMT)
1 Year Microgen Chart |
1 Month Microgen Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions